Merrimack Pharmaceuticals
MACK
#7823
Rank
S$0.30 B
Marketcap
$20.37
Share price
0.00%
Change (1 day)
19.23%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -S$3.05 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$2.93 Million a decrease over its 2022 earnings that were of -S$2.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$3.05 Million4.02%
2023 -S$2.93 Million0.09%
2022 -S$2.93 Million-16.9%
2021 -S$3.53 Million-49.89%
2020 -S$7.03 Million-75.39%
2019 -S$28.56 Million-68.58%
2018 -S$90.87 Million-19.4%
2017 -S$0.12 Billion-36.46%
2016 -S$0.18 Billion2.54%
2015 -S$0.18 Billion96.78%
2014 -S$87.94 Million-45.44%
2013 -S$0.17 Billion
2010 -S$62.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.97 B-328,025.63%๐Ÿ‡ซ๐Ÿ‡ท France
-S$39.09 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.29 Billion 9,125.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.3 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$29.22 Million 860.69%๐Ÿ‡บ๐Ÿ‡ธ USA